Tsukanov Yurii T, Nikolaichuk Aleksandr I
Department of Surgical Diseases, Omsk State Medical University, Omsk, Russia -
Department of Surgical Diseases, Omsk State Medical University, Omsk, Russia.
Int Angiol. 2017 Apr;36(2):189-196. doi: 10.23736/S0392-9590.16.03708-1. Epub 2016 Jun 17.
Orthostatic loading can induce transient venous reflux (TVR). Among patients with telangiectasia and reticular varices, we determined the proportion that developed TVR after a day of orthostatic loading (DOL test), and investigated the remedial effects of micronized purified flavonoid fraction (MPFF).
All 96 patients enrolled in this study had telangiectasia and reticular varices. Patients underwent duplex scanning (DS) in the morning and evening, and vein diameters were measured. Patients with detectable evening TVR were treated daily with MPFF (Daflon® 1000 mg; Servier, Suresnes, France) for 90 days, and then reassessed. Patient quality of life (QOL) was evaluated using the Chronic Venous Insufficiency Questionnaire (CIVIQ-20).
At baseline, patients had telangiectasia (45.8%), reticular varices (13.5%), or both (40.7%). TVR was absent in all patients in the morning but present in over half of them (55.2%) in the evening. All TVR patients complained of leg heaviness versus 16.3% of non-TVR patients. The great saphenous vein (GSV) diameters of patients with TVR were significantly greater than those without (Р<0.0001). After MPFF treatment, TVR was eliminated in most patients (92.5%). The GSV diameter in treated patients was significantly reduced from baseline (5.69-5.14 mm; Р=0.000001). The majority of patients (88.6%) no longer experienced leg heaviness, with 11.4% having reduced symptoms. QOL improved.
More than half of the patients with telangiectasia and reticular varices experience TVR. TVRs can be exposed using the DOL test, which has no impact upon daily life. Daily MPFF (Daflon® 1000 mg) treatment over 90 days eliminated TVR, resolved venous symptoms, and improved QOL.
直立负荷可诱发短暂性静脉反流(TVR)。在患有毛细血管扩张和网状静脉曲张的患者中,我们确定了在一天的直立负荷(DOL试验)后出现TVR的患者比例,并研究了微粉化纯化黄酮类成分(MPFF)的治疗效果。
本研究纳入的所有96例患者均患有毛细血管扩张和网状静脉曲张。患者在早晨和晚上接受双功超声扫描(DS),并测量静脉直径。检测到夜间TVR的患者每天接受MPFF(达芙通®1000 mg;施维雅公司,法国叙雷讷)治疗90天,然后重新评估。使用慢性静脉功能不全问卷(CIVIQ-20)评估患者的生活质量(QOL)。
基线时,患者患有毛细血管扩张(45.8%)、网状静脉曲张(13.5%)或两者皆有(40.7%)。所有患者早晨均无TVR,但晚上超过半数患者(55.2%)出现TVR。所有TVR患者均主诉腿部沉重,而非TVR患者中这一比例为16.3%。TVR患者的大隐静脉(GSV)直径显著大于无TVR患者(P<0.0001)。MPFF治疗后,大多数患者(92.5%)的TVR消失。治疗患者的GSV直径较基线显著减小(5.69 - 5.14 mm;P = 0.000001)。大多数患者(88.6%)不再有腿部沉重感,11.4%的患者症状减轻。QOL得到改善。
超过半数的毛细血管扩张和网状静脉曲张患者存在TVR。可通过DOL试验检测出TVR,且该试验对日常生活无影响。90天的每日MPFF(达芙通®1000 mg)治疗消除了TVR,缓解了静脉症状,并改善了QOL。